Generali Investments CEE’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58M Sell
3,155
-180
-5% -$86.4K 0.08% 235
2026
Q1
$1.64M Sell
3,335
-320
-9% -$174K 0.09% 228
2025
Q4
$2.12M Hold
3,655
– – 0.15% 178
2025
Q3
$1.77M Sell
3,655
-100
-3% -$46.5K 0.13% 183
2025
Q2
$1.52M Hold
3,755
– – 0.13% 188
2025
Q1
$1.87M Sell
3,755
-215
-5% -$116K 0.17% 169
2024
Q4
$2.07M Buy
+3,970
New +$2.18M 0.21% 144

Other funds holding TMO

Generali Investments CEE's TMO Position: Q2 2026 in Review

Generali Investments CEE reduced its Thermo Fisher Scientific (TMO) stake by 5.4% in Q2 2026, selling an estimated $86.4K and leaving 3,155 shares worth $1.58M. The position accounts for 0.08% of the portfolio, ranked #235.

Generali Investments CEE first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.12M in Q4 2025. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Generali Investments CEE held 3,155 shares of Thermo Fisher Scientific worth $1.58M as of Q2 2026.
  • Generali Investments CEE sold 180 Thermo Fisher Scientific shares in Q2 2026, an estimated $86.4K.
  • Thermo Fisher Scientific made up 0.08% of Generali Investments CEE's portfolio in Q2 2026, its #235 holding.
  • Generali Investments CEE first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Generali Investments CEE's Thermo Fisher Scientific position peaked at $2.12M in Q4 2025.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.